Dear friends,
I’m thrilled to share our 2025 Annual Report: A Future within Reach. In a year of unprecedented pressure on global health, our network grew, our health programs reached more patients, and the case for our model only grew stronger. We ended 2025 with a number of all-time milestones:
- Over 5,000 active sites, with full-time operations in Kenya, Uganda, Tanzania, and Nigeria.
- 63 million patient visits to date, including a record 25.6 million in 2025 alone.
- 1.2 million of these visits directly supported by our reimbursement-driven health programs in malaria, HIV, vision, and more.
- New government partnerships led Lagos State to adopt our malaria program into its own budget, marking a transition from donor-funded to government-financed care; and Uganda awarded us our first Global Fund award to scale malaria care and HIV prevention nationwide.
Like many organizations, 2025 brought hard choices, uncertain timelines, and the loss of committed funding. But we kept moving because we knew this was when our work mattered most. The model we’d spent years building, without fully knowing what it would be tested against, turned out to answer the question: “What does global health look like when the old models stop working?”
Moreover, the global conversation has sharpened its focus not just on how to deliver health services, but how to finance them. And we’ve increasingly found ourselves part of that conversation because, besides delivering care on the ground, our health programs have also built entire backend auditing and claims platforms. This new infrastructure makes it possible to pay directly for verified results, reflecting the kinds of financing models that governments and funders are increasingly calling for.
Right now, there’s a once-in-a-generation opportunity to redefine how healthcare is delivered and financed across Africa. We don’t intend to let this defining moment pass. The pressures facing global health are real, but so is the opportunity to build systems that are more effective, accountable, and sustainable. And so we’re going to keep moving—solving immediate problems while designing for the future. And we’re grateful to everyone who’s moving alongside us.
With deep gratitude,
Jessica Vernon, MD
CEO, Maisha Meds
